Bayer AG (BAYGn.DE) Key Developments | Reuters.com
Edition:
United States

Bayer AG (BAYGn.DE)

BAYGn.DE on Xetra

86.98EUR
11:35am EDT
Change (% chg)

€-0.66 (-0.75%)
Prev Close
€87.64
Open
€87.20
Day's High
€89.95
Day's Low
€86.49
Volume
4,275,041
Avg. Vol
3,071,829
52-wk High
€138.00
52-wk Low
€83.45

Latest Key Developments (Source: Significant Developments)

Bayer proposes increased dividend for FY 2015 of EUR 2.50 per share
Thursday, 25 Feb 2016 09:04am EST 

Bayer AG:Proposes increased dividend for FY 2015 of EUR 2.50 per share.  Full Article

Bayer gives FY 2016 outlook with sales outlook in line with analysts' estimates
Wednesday, 24 Feb 2016 07:00pm EST 

Bayer AG:In FY 2016, the Bayer Group including Covestro is planning sales of more than 47 billion euros.Plans to increase FY 2016 EBITDA before special items by a mid-single-digit percentage.FY 2016 revenue estimate 48.34 billion euros - Thomson Reuters I/B/E/S.  Full Article

Bayer AG names strategy chief Baumann as new CEO
Tuesday, 23 Feb 2016 07:00pm EST 

Bayer AG:Werner Baumann to become new chief executive, replacing Marijn Dekkers.Baumann will take over on May 1.Dekkers' contract, which has been due to run until the end of 2016, will be dissolved at end of April.  Full Article

Bayer AG receives EU approval for Kovaltry for haemophilia A
Sunday, 21 Feb 2016 07:00pm EST 

Bayer AG:EU approves Bayer's haemophilia A Kovaltry for the treatment of patients from all age groups.  Full Article

Bayer AG acquires software provider Proplant​ - Reuters
Monday, 15 Feb 2016 05:35am EST 

Bayer AG:Bolsters digital farming through acquisition of software provider Proplant - Reuters.The company based in Muenster was originally established as a spin-off by employees of the Institute for Geoinformatics at Muenster University.It will operate as Bayer Digital Farming GmbH in the future​.  Full Article

Bayer AG rejects EPA request to pull insecticide from U.S. market - Reuters
Friday, 5 Feb 2016 09:00am EST 

Bayer AG:Bayer AG said on Friday it will fight a U.S. Environmental Protection Agency (EPA) request to pull one of its insecticides from the marketplace amid concerns that it could harm organisms in streams and ponds. - RTRS.Bayer CropScience will instead ask for an administrative law hearing from the EPA's Office of General Counsel to review the registration of flubendiamide, the active ingredient in Bayer's Belt pesticide. - RTRS.The pesticide, launched in 2008, is used to control yield-damaging moths and worms in more than 200 crops including almonds, oranges and soybeans. - RTRS.Bayer's own tests have found that the pesticide is toxic in high doses to invertebrates in river and pond sediment. - RTRS.The organisms can be an important food source for fish. However, the company's field studies showed that doses in waters near agricultural fields never reached high enough levels to be toxic. - RTRS.But the EPA's risk assessment disagreed so the agency sent Bayer the request on Jan. 29.After rejecting the EPA's request, Bayer now expects the agency to issue a formal request to cancel its registration of the pesticide. - RTRS.After a comment period mandated by U.S. pesticide regulation law, Bayer will ask for a formal hearing to determine the pesticide's fate. - RTRS.  Full Article

Bayer AG - Widely used pesticide can harm bees in some cases -EPA - Reuters
Wednesday, 6 Jan 2016 05:28pm EST 

Bayer AG:An insecticide widely used on cotton plants and citrus groves can harm bees that come into contact with those crops under certain conditions, the U.S. Environmental Protection Agency said on Wednesday. - RTRS.The agency said a preliminary risk assessment of imidacloprid, a neonicotinoid insecticide chemically similar to nicotine, found that chemical residues of more than 25 parts per billion would likely harm bees and their hives and result in the bees producing less honey - RTRS.The EPA, which collaborated with California's Department of Pesticide Regulation, said data showed imidacloprid residues in pollen and nectar above that threshold level in citrus and cotton crops - RTRS.But residues found on corn and leafy vegetables were below at-risk levels, the agency said. Some crops needed more testing. - RTRS.The federal agency is expected to finalize a broader assessment of risks the chemical may pose to pollinators by the end of the year - RTRS.On Wednesday, the Center for Food Safety and a coalition of farmers and agriculture groups filed a lawsuit against the EPA, accusing it of failed oversight over millions of pounds of neonic-coated seeds sold and planted. - RTRS.Bayer CropScience, Syngenta AG and other firms that produce or sell neonic products have said mite infestations and other factors are to blame for bee deaths. - RTRS.  Full Article

Bayer closes on divestiture of Diabetes Care business
Monday, 4 Jan 2016 07:00pm EST 

Bayer AG:Closes on divestiture of Diabetes Care business to Panasonic Healthcare Holdings Co., Ltd. for around 1 billion euros.  Full Article

Bayer AG - Trial for Bayer's Xarelto under scrutiny over defective device - Reuters
Tuesday, 8 Dec 2015 07:27am EST 

Bayer AG:European and U.S. drug safety agencies are looking into whether a defective blood-clotting test device affected a trial involving Bayer's BAYGn.DE anti-blood clotting drug Xarelto, they said on Tuesday - RTRS.The study compared Xarelto, also known as rivaroxaban, with older drug warfarin for the prevention of stroked and systemic embolisms in patients with irregular heartbeat. - RTRS."Due to the defect it is now thought that the INR (international normalised ratio) device may have impacted the clotting results in some patients in the warfarin group," the European Medicines Agency said in a statement - RTRS.adding it will publish the results when the investigation is complete - RTRS.The U.S. Food and Drug Administration also said it was "aware of concerns regarding the INR device and its use in the Rocket AF trial and is reviewing relevant data". - RTRS.Germany-based Bayer said it had conducted a number of sensitivity analyses that confirmed the results of the clinical trial. - RTRS."Bayer is working closely with health authorities to address any questions they may have," a spokeswoman said in an emailed statement. "Study after study continues to confirm that Xarelto is performing as expected with a positive benefit-risk profile." - RTRS.The investigation was first reported by German daily Handelsblatt.  Full Article

Bayer files for EU, U.S. approval for new contraceptive
Thursday, 19 Nov 2015 07:00pm EST 

Bayer AG:Has filed for marketing approval in the European Union and the United States for its new five-year contraceptive LCS-16.LCS-16 is a new low-dose levonorgestrel-releasing intrauterine system (LNG-IUS) which is directly placed in the uterus for contraception for up to five years.  Full Article

Bayer, Dupont join ag-tech investment boom to ease grain pain

CHICAGO Dupont and Bayer AG have teamed up to invest in a new fund that will back agricultural technology startups, becoming the latest companies to pile into the multibillion-dollar industry as farm profits shrink.